The AJMC® HIV compendium is a comprehensive resource for clinical news and expert insights for the condition, including disparities in care, prevention of infection among at-risk groups, and the importance of viral suppression.
January 2nd 2026
Medicare HIV cases are projected to double by 2035, with cumulative costs reaching $195.6 billion and creating critical challenges for federal funding.
Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care
1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health
View More
Payment for Pharmacist Services: 2025 Update
1.0 Credit / General Pharmacy, Health Equity, Diversity & Inclusion, Law
View More
HIV-1 Virulence Appears More Potent Among Heterosexual Individuals
March 10th 2022This new study evaluated the influence of transmission bottlenecks on HIV-1 infection virulence by comparing outcomes between penile-vaginal intercourse and anal intercourse, and found more severe disease among heterosexual individuals compared with men who have sex with men.
Read More
HIV, HCV Testing Availability Stagnates Despite Growing Number of Substance Use Treatment Facilities
March 3rd 2022Although thousands of new substance use disorder treatment facilities that offer medication for opioid use disorder were opened between 2017 and 2020, the proportion of facilities that also offered HIV and hepatitis C virus (HCV) testing hardly changed.
Read More
CROI Abstract Shows Drop in Neurocognitive Deficit Among PLWH
February 26th 2022An abstract presented at this year’s Conference on Retroviruses and Opportunistic Infections (CROI) bore out the results of an Italian investigation into a potential link between persons living with HIV (PLWH) taking newer antiretroviral therapies and neurocognitive disorder prevalence.
Read More
Drop in HIV PrEP Prescriptions, New Users Observed During COVID-19 Pandemic
February 25th 2022A data analysis found a 22% reduction in HIV pre-exposure prophylaxis (PrEP) prescriptions and a 25% reduction in new PrEP users in the United States after COVID-19 was declared a national emergency.
Read More
Real-world HIV Diagnostic Testing Patterns in the United States
This retrospective study evaluated real-world implementation of the updated CDC HIV algorithm in a large US laboratory.
Read More
CHIVA CEO Amanda Ely Explains How Fraser Guidelines Can Help Children With HIV
December 28th 2021The Fraser guidelines can indicate if a child is fully competent to make their own decisions, including consenting to HIV tests if they may be at risk, explained Amanda Ely, CEO of the Children’s HIV Association (CHIVA) of the United Kingdom and Ireland.
Watch
What We’re Reading: Free At-Home COVID-19 Tests; Aduhelm Price Cuts; First Injectable HIV Preventive
December 21st 2021Up to 500 million at-home COVID-19 test kits will be sent to US households for free, by request; Biogen cut the price of its Alzheimer disease drug Aduhelm nearly in half; the FDA approved the world’s first injectable medication to reduce the risk of sexually transmitted HIV.
Read More
Dr Jason Myers on the Stigma Against New Zealanders Living With HIV
December 20th 2021Jason Myers, PhD, CEO, of the New Zealand AIDS Foundation, explains how they conducted a New Zealand version of the Stigma Index Research to solve the issue of Māori living with HIV experiencing worsened stigma and discrimination.
Watch